Long-term prospective clinical follow-up afterBRCA1/2presymptomatic testing:BRCA2risks higher than in adjusted retrospective studies

Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

(2013) Richard M Brohet et al.   JOURNAL OF MEDICAL GENETICS

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

(2013) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

(2013) Fergus J. Couch et al.   PLoS Genetics

Differences in Natural History between Breast Cancers in BRCA1 and BRCA2 Mutation Carriers and Effects of MRI Screening-MRISC, MARIBS, and Canadian Studies Combined

(2012) E. A. M. Heijnsdijk et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Is multiple SNP testing inBRCA2andBRCA1female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UK

(2012) SL Ingham et al.   CLINICAL GENETICS

Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

(2010) C. Engel et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

(2010) A. C. Antoniou et al.   CANCER RESEARCH

Genome-wide association study identifies five new breast cancer susceptibility loci

(2010) Clare Turnbull et al.   NATURE GENETICS

Eligibility for Magnetic Resonance Imaging Screening in the United Kingdom: Effect of Strict Selection Criteria and Anonymous DNA Testing on Breast Cancer Incidence in the MARIBS Study

(2009) D. G. R. Evans et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Penetrance estimates for BRCA1 and BRCA2based on genetic testing in a Clinical Cancer Genetics service setting: Risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

(2008) D Gareth Evans et al.   BMC CANCER

Erratum: The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions

(2008) A C Antoniou et al.   BRITISH JOURNAL OF CANCER

Risk reducing mastectomy: outcomes in 10 European centres

(2008) D G R Evans et al.   JOURNAL OF MEDICAL GENETICS